H. Mameghan

发表

Heterogeneity of in vitro radiosensitivity in human bladder cancer cells.

J. Ribeiro, A. Barnetson, P. Russell, 1999, Radiation oncology investigations.

Relationship between radiation response and p53 status in human bladder cancer cells.

J. Ribeiro, A. Barnetson, P. Russell, 1997, International journal of radiation biology.

Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours

W. McWhirter, H. Mameghan, I. Toogood, 1993, Cancer Chemotherapy and Pharmacology.

A case–control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects

M. Frydenberg, M. Frydenberg, H. Mameghan, 2001, Cancer.

The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma.

K. Ow, R. Fisher, H. Mameghan, 1995, Urologic oncology.

Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indication.

H. Mameghan, R. Grundy, D. Raghavan, 1988, British journal of urology.

Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?

R. Wines, H. Mameghan, D. Raghavan, 1985, The Journal of urology.

The management of invasive bladder cancer: a review of selected Australasian studies in radiotherapy, chemotherapy and cystectomy.

H. Mameghan, T. Sandeman, 1991, The Australian and New Zealand journal of surgery.

Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial.

R. Fisher, H. Mameghan, J. Kearsley, 2004, International journal of radiation oncology, biology, physics.

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.

H. Mameghan, N. Spry, J. Matthews, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Testicular doses in definitive radiation therapy for localized prostate cancer.

R. Fisher, H. Mameghan, C. Amies, 1995, International journal of radiation oncology, biology, physics.

Allogeneic and autologous bone marrow transplantation for acute non‐lymphoblastic leukaemia

H. Mameghan, M. Vowels, A. Trickett, 1994, Journal of paediatrics and child health.

Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens.

H. Mameghan, D. Raghavan, P. Langdon, 1991, Seminars in oncology.

Symptom duration and delay in referral for palliative radiotherapy in cancer patients: a pilot study

H. Mameghan, D. Ball, J. Corry, 1998, The Medical journal of Australia.

Bone marrow transplantation for acute leukaemia in childhood

J. Ziegler, H. Mameghan, M. Vowels, 1982, Australian paediatric journal.

Bone marrow transplantation for malignant histiocytosis in childhood

H. Mameghan, J. Ziegler, M. Vowels, 1985, Cancer.

Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.

Peter Shaw, H. Mameghan, G. McCowage, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow transplantation for childhood acute lymphoblastic leukaemia after marrow relapse

H. Mameghan, G. Marshall, A. Trickett, 1990, The Medical journal of Australia.

Bone‐marrow transplantation for haematological malignancy in childhood

J. Ziegler, H. Mameghan, D. O'Gorman-Hughes, 1986, The Medical journal of Australia.

Response of melanoma to heat and radiation therapy —a review of the literature and experience from The Prince of Wales Hospital, Sydney

H. Mameghan, T. Knittel, T. Knittel, 1988, The Medical journal of Australia.

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

C. D’Este, D. Joseph, H. Mameghan, 2005, The Lancet. Oncology.

Second intracranial neoplasms following treatment of childhood acute lymphoblastic leukaemia

H. Mameghan, V. Tobias, M. Vowels, 1991, Journal of paediatrics and child health.

Iodine-125 irradiation of choroidal melanoma: clinical experience from the Prince of Wales and Sydney Eye Hospitals.

R. Fisher, H. Mameghan, F. Billson, 1992, Australasian radiology.

The development of a treatment protocol for patients with chronic radiation-induced rectal bleeding.

H. Mameghan, O. Dent, P. Chapuis, 1996, The Australian and New Zealand journal of surgery.

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.

R. Fisher, H. Mameghan, J. Mameghan, 1995, International journal of radiation oncology, biology, physics.

Ewing's sarcoma: long-term follow-up in 49 patients treated from 1967 to 1989.

R. Fisher, H. Mameghan, D. O'Gorman-Hughes, 1993, International journal of radiation oncology, biology, physics.

Results of radiotherapy for localised prostatic carcinoma treated at the Prince of Wales Hospital, Sydney

R. Fisher, H. Mameghan, R. Farnsworth, 1991, The Medical journal of Australia.

Radiation hepatitis following moving strip radiotherapy.

H. Mameghan, M. Feigen, L. Peters, 1983, International journal of radiation oncology, biology, physics.

Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.

A. Barnetson, P. Russell, D. Banasiak, 1999, Radiation oncology investigations.

Clinical thermoluminescence dosimetry: how do expectations and results compare?

H. Mameghan, T. Kron, M. Schneider, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma: prognostic factors and implications for curative therapy.

R. Fisher, H. Mameghan, I. Kern, 1993, Medical and pediatric oncology.

Synchronous cisplatin infusion during radiotherapy for the treatment of metastatic melanoma.

A. Coates, R. Kefford, G. Stevens, 1991, European journal of cancer.

Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukaemia.

H. Mameghan, N. Giri, M. Vowels, 1992, Bone marrow transplantation.

Prostate cancer and PSA screening.

H. Mameghan, 1999, Australian family physician.

Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect.

R. Fisher, H. Mameghan, J. Mameghan, 1990, International journal of radiation oncology, biology, physics.

A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).

D. Joseph, H. Mameghan, N. Spry, 2000, Australasian radiology.

Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.

C. D’Este, D. Joseph, H. Mameghan, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.

D. Joseph, H. Mameghan, N. Spry, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.

R. Fisher, H. Mameghan, J. Kearsley, 2001, International journal of radiation oncology, biology, physics.

Invasive bladder cancer. Prognostic factors and results of radiotherapy with and without cystectomy.

R. Fisher, H. Mameghan, 1989, British journal of urology.

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the prince of Wales hospital, Sydney, Australia

R. Fisher, H. Mameghan, E. Korbel, 1992, Cancer.

The efficacy of treatment for malignant epidural spinal cord compression.

R. Fisher, H. Mameghan, C. Milross, 1997, Australasian radiology.

Prostate cancer in Victoria in 1993: patterns of reported management

G. Giles, M. Frydenberg, H. Mameghan, 2000, The Medical journal of Australia.

Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinoma.

J. Grygiel, H. Mameghan, D. Raghavan, 1992, British journal of urology.

Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate.

R. Fisher, H. Mameghan, J. Mameghan, 1994, The Australian and New Zealand journal of surgery.